|
|
Clinical study of circulating blood tumor cell detection in the evaluation after radical cystectomy |
KANG Xi LI qin LIU fang |
Department of Urology, Pingxiang People′s Hospital, Jiangxi Province, Pingxiang 337000, China |
|
|
Abstract Objective To investigate the application value of circulating tumor cells (CTC) in the evaluation of radical cystectomy.Methods From June 2018 to October 2019, ninety patients with bladder cancer undergoing radical cystectomy in Pingxiang People′s Hospital were selected as the study group, and ten non tumor patients in Pingxiang People′s Hospital at the same time were selected as the control group.Before operation, 7.5 mL of peripheral venous blood was collected and separated by negative enrichment method.Peripheral CTC was detected by immunofluorescent in situ hybridization (imFISH) detection technology.The relationship between the positive rate of CTC and clinicopathological characteristics of bladder cancer patients, and the relationship between CTC expression level and prognosis of bladder cancer patients were analyzed.Results The positive detection rate of CTC in the study group was higher than that in the control group, the difference was statistically significant (P<0.05).The CTC positive rate of multiple tumors was higher than that of single tumor, the CTC positive rate of tumor diameter ≥3 cm was higher than that of <3 cm, the CTC positive rate of ≥T2 stage was higher than that of <T2 stage, the CTC positive rate of high-grade tumors was higher than that of low-grade tumors, the CTC positive rate of recurrent patients was higher than that of non-recurrence patients, and the differences were statistically significant (P<0.05).The survival curve showed that the survival rate of CTC positive expression was higher than that without CTC positive table, the difference was statistically significant (P<0.05).Conclusion CTC is closely related to tumor number, tumor diameter, pathological grade, T stage and recurrence of bladder cancer.The expression of CTC is closely related to the prognosis of patients with bladder cancer, which can be used as an independent index to predict the prognosis of bladder cancer.
|
|
|
|
|
[1] |
张晓乐,李庆文.根治性经尿道膀胱肿瘤电切术联合化疗及益气活血通络法治疗肌层浸润性膀胱癌疗效观察[J].现代中西医结合杂志,2018,27(15):1619-1622.
|
[2] |
管庆军,单中杰,韩前河,等.术前外周血NLR、PLR 在经尿道非肌层浸润性膀胱肿瘤切除术预后中的意义[J].临床泌尿外科杂志,2018,33(7):545-550.
|
[3] |
严勇,孙洵,李岗,等.膀胱癌患者外周血循环肿瘤细胞中Survivin 的表达[J].昆明医科大学学报,2017,38(7):102-106.
|
[4] |
唐芮鹏,刘建和,李炯明,等.CTCs 在膀胱癌转移及预后评估中应用的研究[J].现代泌尿生殖肿瘤杂志,2017,9(2):76-79.
|
[5] |
陈威鹏,李印,袁东风,等.食管鳞癌外周血循环肿瘤细胞与临床病理特征的关系[J].中华实验外科杂志,2019,36(3):546-549.
|
[6] |
张潇分,贾春平,陈宏梅,等.外周血循环肿瘤细胞和游离DNA 联合检测在乳腺癌辅助诊断中的临床价值[J].中华检验医学杂志,2019,42(8):662-668.
|
[7] |
吴岑,郑志雄,黄志扬,等.膀胱癌患者外周血中循环肿瘤细胞的监测及临床意义研究[J].癌症进展,2019,17(9):1068-1071.
|
[8] |
王力伟,周晓洲,陈志文,等.膀胱癌循环肿瘤细胞NANOG基因的表达与临床特征相关性的初步研究[J].第三军医大学学报,2018,40(8):711-716.
|
[9] |
刘佳,曹煜东,汤星星,等.检测循环肿瘤细胞对预测尿路上皮癌淋巴结转移的价值[J].中华泌尿外科杂志,2019,40(12):885-888.
|
[10] |
赵欣,纪志刚.一种新的循环肿瘤细胞检测平台在膀胱癌诊疗中的初步应用[J].癌症进展,2017,15(10):1142-1144,1199.
|
[11] |
曹霞,吴伟,赵小玉,等.早中期结直肠癌手术前后外周血循环肿瘤细胞的 监测及预后分析[J].中山大学学报(医学科学版),2019,40(4):604-614.
|
[12] |
李建华,徐鹏飞,邓真,等.甲状腺乳头状癌患者术后外周血循环肿瘤细胞检测及临床意义[J].中华实验外科杂志,2019,36(4):731-733.
|
[13] |
张国贤,冯锦锦,朱文,等.膀胱癌根治性膀胱全切患者外周血循环肿瘤细胞与凝血及临床病理指标的相关性[J].中华实验外科杂志,2019,36(2):333-335.
|
[14] |
肖瑶,朱光发,张颖,等.外周血活性循环肿瘤细胞与非小细胞肺癌患者临床特征的相关性及其临床意义[J].中国医药,2019,14(4):526-529.
|
[15] |
张月,韩振国.循环肿瘤细胞和血清肿瘤标志物联合检测对结直肠癌术后复发或转移的预测价值[J].中国药物与临床,2019,19(3):390-391.
|
|
|
|